Esta web utiliza cookies técnicas, de personalización y análisis, propias y de terceros,
para facilitarle la navegación y analizar estadísticas del uso de la web.
Si continúa navegando, consideramos que acepta su uso
Managing urologic cancer by preserving, as opposed to removing, affected tissue, is rapidly becoming the favoured choice for urologists and oncologists. Discover all available options and how to achieve the best possible patient management with this expert guide to the area. The editor, Mark Schoenberg, is an internationally-renown expert in this exciting new area and has recruited an outstanding team featuring some of the leading urologists/oncologists in North America and Europe to assist him.
Table of Contents
Introduction - The historical basis of tissue preserving strategies in surgical oncology.
Section 1: The biologic basis for tissue preservation
2. Cancer genetics, cancer biology and tumor growth and metastasis: the interaction of cancer and its immediate host environment.
3. Pathological basis of tumor characterization: cytopathology, surgical pathology and how histo-morphology informs treatment decision-making (Kidney, Prostate, Bladder and other tumor systems)
4: The immunobiology of tumor ablation
5. Cancer epidemiology: how it impacts clinical decision-making
Section 2: Diagnosis and the analysis of risk
6: Imaging and cancer detection: the promise and limitations of non-invasive technology
7: Ultrasound and the detection of urologic cancers
8: Computed tomography
9: Magnetic resonance and metabolic imaging (PET, PET-CT, Bone-scanning, new contrast agents)
10: Biopsy strategies in the analysis of urologic neoplasia
11: Subcellular analytics and the emerging field of molecular profiling and risk stratification (genomics, proteomics, metabolomics)
Section 3: The treatment of urologic cancers
12: Tissue preserving surgical approaches in urologic oncology: the therapeutic mechanism of tumor ablation
13: Imaging and the modern operating room: registration, treatment planning and conduct
14: Prostate cancer: an evidence-based approach to tissue preserving strategies (Radiation therapy, cryoablation, radiofequency ablation, electroporation, high intensity focused ultrasound)
15: The modern basis for nephron-sparing surgery in patients with renal cancer: biologic heterogeneity, the signficance of tumor biopsy and the changing the roles of partial nephrectomy and tumor ablation
16: Bladder preserving strategies in the treatment of urothelial cancer: the disease spectrum and the dawn of molecular surgical guidance
17: Adrenal surgery: the relevance of tissue preservation